Predictions
Cutera Inc.
Start price
Target price
Perf. (%)
€16.30
19.10.20
19.10.20
€20.00
02.11.20
02.11.20
-0.61%
02.11.20
02.11.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
19.10.20
19.10.20
€10.00
02.11.20
02.11.20
-
02.11.20
02.11.20
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€12.90
17.10.20
17.10.20
-
04.11.21
04.11.21
-29.07%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Risky balance sheet
QuidelOrtho Corp.
Start price
Target price
Perf. (%)
€212.00
06.10.20
06.10.20
-
04.11.21
04.11.21
-44.10%
05.11.21
05.11.21
Innovative
Higher risks for its business
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.70
05.10.20
05.10.20
€15.00
19.10.20
19.10.20
-17.52%
19.10.20
19.10.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€10.70
05.10.20
05.10.20
€13.00
19.10.20
19.10.20
14.02%
19.10.20
19.10.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€15.70
05.10.20
05.10.20
€20.00
19.10.20
19.10.20
3.82%
19.10.20
19.10.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
05.10.20
05.10.20
€1.00
19.10.20
19.10.20
-
19.10.20
19.10.20
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€9.45
23.09.20
23.09.20
-
04.11.21
04.11.21
-47.51%
15.07.21
15.07.21
Probably not worthwhile Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€9.90
22.09.20
22.09.20
-
04.11.21
04.11.21
-49.70%
05.11.21
05.11.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€7.40
21.09.20
21.09.20
-
28.09.20
28.09.20
40.54%
28.09.20
28.09.20
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€7.40
19.09.20
19.09.20
-
29.09.20
29.09.20
72.97%
29.09.20
29.09.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€7.40
19.09.20
19.09.20
-
23.09.20
23.09.20
34.46%
23.09.20
23.09.20
Could be very worthwhile Investment >20% year
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.20
16.09.20
16.09.20
€12.00
21.09.20
21.09.20
9.82%
21.09.20
21.09.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€6.70
16.09.20
16.09.20
€8.00
21.09.20
21.09.20
5.97%
21.09.20
21.09.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€16.40
16.09.20
16.09.20
€18.00
21.09.20
21.09.20
0.00%
21.09.20
21.09.20
Could be worthwhile Investment >10% per year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
16.09.20
16.09.20
€0.000
21.09.20
21.09.20
-
21.09.20
21.09.20
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€4.94
06.09.20
06.09.20
-
19.09.20
19.09.20
49.80%
19.09.20
19.09.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.02
03.09.20
03.09.20
-
03.09.20
03.09.20
-
03.09.20
03.09.20
High risks for its business
PerkinElmer Inc.
Start price
Target price
Perf. (%)
€104.00
03.09.20
03.09.20
-
04.11.21
04.11.21
9.62%
05.11.20
05.11.20
Growths faster than the competition
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.65
22.08.20
22.08.20
-
03.09.20
03.09.20
-11.28%
03.09.20
03.09.20
High risks for its business
Motus GI Holdings Inc.
Start price
Target price
Perf. (%)
€16.70
22.08.20
22.08.20
-
04.11.21
04.11.21
-2.40%
03.06.21
03.06.21
Could be very worthwhile Investment >20% year
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
20.08.20
20.08.20
€2.00
23.08.20
23.08.20
-
23.08.20
23.08.20
Could be very worthwhile Investment >20% year
Idexx Laboratories Inc.
Start price
Target price
Perf. (%)
€321.10
15.08.20
15.08.20
-
16.10.20
16.10.20
12.64%
16.10.20
16.10.20
EBIT growth >5% per year expected
Very low/no dividend yield expected